| 詳細情報 |   |
|---|---|
| 関連リンク |  |
| 探す |  |
論文 (64件)
- Tatsuya Terasaki, Semba Y, Kensuke Sasaki, Hiroshi Imanaga, Setoguchi K, Yamauchi T, Shigeki Hirabayashi, Nakao F, Akahane K, Inukai T, et al. The RNA helicases DDX19A/B modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells. Leukemia. 2024
- Ryo Yanagiya, Miyatake Y, Watanabe N, Shimizu T, Kanamori A, Masaya Ueno, Okabe S, Joaquim Carreras, Nakayama S, Hasegawa A, et al. Amino acid influx via LAT1 regulates iron demand and sensitivity to PPMX-T003 of aggressive natural killer cell leukemia. Leukemia. 2024
- Hiroshi Imanaga, Yuichiro Semba, Kensuke Sasaki, Kiyoko Setoguchi, Hillary Maniriho, Takuji Yamauchi, Tatsuya Terasaki, Shigeki Hirabayashi, Fumihiko Nakao, Jumpei Nogami, et al. Central role of the mTORC1 pathway in glucocorticoid activity against B-ALL cells. Blood Neoplasia. 2024
- Kyoko Yamaguchi, Mamoru Ito, Taichi Isobe, Sakuya Koreishi, Ryosuke Taguchi, Koki Uehara, Shohei Ueno, Takashi Imajima, Takafumi Kitazono, Kenji Tsuchihashi, et al. Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer. JCO Precision Oncology. 2024. 8
- Yasunori Kogure, Handa H, Yuta Ito, Masaki Ri, Horigome Y, Iino M, Yoriko Harazaki, Takahiro Kobayashi, Masahiro Abe, Tadao Ishida, et al. ctDNA improves prognostic prediction in relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone. Blood. 2024
- Sunami K, Naito Y, Saigusa Y, Amano T, Ennishi D, Imai M, Kage H, Kanai M, Kenmotsu H, Komine K, et al. A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence. JAMA oncology. 2024
- Horigome Y, Iino M, Harazaki Y, Kobayashi T, Handa H, Hiramatsu Y, Kuroi T, Tanimoto K, Matsue K, Abe M, et al. A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan. Annals of hematology. 2023
- Takahiro Maeda. CELMoD for ALL: an exciting prospect. Blood. 2023
- Yosuke Komata, Akinori Kanai, Takahiro Maeda, Toshiya Inaba, Akihiko Yokoyama. MOZ/ENL complex is a recruiting factor of leukemic AF10 fusion proteins. Nature Communications. 2023
- Nakao F, Setoguchi K, Semba Y, Yamauchi T, Nogami J, Sasaki K, Imanaga H, Terasaki T, Miyazaki M, Shigeki Hirabayashi, et al. Targeting a mitochondrial E3 ubiquitin ligase complex to overcome AML cell-intrinsic Venetoclax resistance. Leukemia. 2023
- Michitaka Nakano, Taguchi R, Kikushige Y, Taichi Isobe, Kohta Miyawaki, Mizuno S, Tsuruta N, Hanamura F, Yamaguchi K, Yamauchi T, et al. RHAMM marks proliferative subpopulation of human colorectal cancer stem cells. Cancer science. 2023
- Naito Y, Sunami K, Kage H, Komine K, Amano T, Imai M, Koyama T, Ennishi D, Kanai M, Kenmotsu H, et al. Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan. JAMA network open. 2022
- Taniguchi S, Utsumi S, Kochi Y, Taya Y, Yasuo Mori, Semba YI, Takeshi Sugio, Miyawaki K, Kikushige Y, Kunisaki Y, et al. Successful pseudo-autologous stem cell transplantation for donor-derived Burkitt lymphoma occurring 9 years after allogeneic transplantation. International journal of hematology. 2022
- Takahiro Maeda. A preterm newborn-onset juvenile myelomonocytic leukemia-like myeloproliferation with PTPN11 mutation. Pediatric blood & cancer. 2022
- Takahiro Maeda. Chronological improvement in precision oncology implementation in Japan. Cancer science. 2022
- Takahiro Maeda. Expert Panel Consensus Recommendations on the Use of Circulating Tumor DNA Assays for Patients with Advanced Solid Tumors. Cancer science. 2022
- Takahiro Maeda. Targeted Degradation of mRNA Decapping Enzyme DcpS by a VHL-Recruiting PROTAC. ACS chemical biology. 2022. 17. 7. 1789-1798
- Takahiro Maeda. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2022. 25. 5. 862-878
- Takuji Yamauchi, Kohta Miyawaki, Yuichiro Semba, Masatomo Takahashi, Yoshihiro Izumi, Jumpei Nogami, Fumihiko Nakao, Takeshi Sugio, Kensuke Sasaki, Luca Pinello, et al. Targeting leukemia-specific dependence on the de novo purine synthesis pathway. Leukemia. 2022. 36. 2. 383-393
- Takahiro Maeda. A Germinal Center-Associated Microenvironmental Signature Reflects Malignant Phenotype and Outcome of DLBCL. Blood advances. 2021
前のページに戻る
